Mark Knickrehm

Mark Knickrehm is a seasoned pharmaceutical sales professional with extensive experience in specialty sales across multiple companies. Currently serving as a Specialty Pharmaceutical Sales Representative at Neurocrine Biosciences since August 2018, Mark has previously held roles at Indivior, where responsibilities included launching and selling injectable medication for opioid addiction, and at Otsuka Pharmaceutical Co., Ltd, promoting the atypical antipsychotic medication Abilify. Mark's experience also includes promoting medications for opioid addiction at Reckitt Benckiser Pharmaceuticals and selling dermatology products as a Pharmaceutical Sales Consultant with Ventiv Health. Mark holds a B.A. in Psychology from Eastern Illinois University, obtained between 1987 and 1991.